Related Articles by Review for PMID: 30521289

Year	Number of Results
1997	1
2003	2
2004	2
2005	2
2006	1
2007	1
2008	1
2018	1
2019	3
2023	2
2024	1
2025	1

1

Singh S, Preuss CV. Singh S, et al. 2024 Jan 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jan 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30521289 Free Books & Documents.

2

The Efficacy of Carvedilol in Comparison to Propranolol in Reducing the Hepatic Venous Pressure Gradient and Decreasing the Risk of Variceal Bleeding in Adult Cirrhotic Patients: A Systematic Review.

Dardari L, Taha M, Dahat P, Toriola S, Satnarine T, Zohara Z, Adelekun A, Seffah KD, Salib K, Arcia Franchini AP. Dardari L, et al. Cureus. 2023 Aug 10;15(8):e43253. doi: 10.7759/cureus.43253. eCollection 2023 Aug. Cureus. 2023. PMID: 37577269 Free PMC article. Review.

3

Carvedilol: a review of its use in chronic heart failure.

Keating GM, Jarvis B. Keating GM, et al. Drugs. 2003;63(16):1697-741. doi: 10.2165/00003495-200363160-00006. Drugs. 2003. PMID: 12904089 Review.

4

Beta-blocker treatment of chronic heart failure: comparison of carvedilol and metoprolol.

Maack C, Elter T, Böhm M. Maack C, et al. Congest Heart Fail. 2003 Sep-Oct;9(5):263-70. doi: 10.1111/j.1527-5299.2003.01446.x. Congest Heart Fail. 2003. PMID: 14564145 Free article. Review.

5

The efficacy comparison of carvedilol plus endoscopic variceal ligation and traditional, nonselective β-blockers plus endoscopic variceal ligation in cirrhosis patients for the prevention of variceal rebleeding: a meta-analysis.

Yang J, Ge K, Chen L, Yang JL. Yang J, et al. Eur J Gastroenterol Hepatol. 2019 Dec;31(12):1518-1526. doi: 10.1097/MEG.0000000000001442. Eur J Gastroenterol Hepatol. 2019. PMID: 31094853 Review.

6

Carvedilol's antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction.

Naccarelli GV, Lukas MA. Naccarelli GV, et al. Clin Cardiol. 2005 Apr;28(4):165-73. doi: 10.1002/clc.4960280403. Clin Cardiol. 2005. PMID: 15869048 Free PMC article. Review.

7

Carvedilol: use in chronic heart failure.

Doughty RN, White HD. Doughty RN, et al. Expert Rev Cardiovasc Ther. 2007 Jan;5(1):21-31. doi: 10.1586/14779072.5.1.21. Expert Rev Cardiovasc Ther. 2007. PMID: 17187454 Review.

8

Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension.

Turco L, Reiberger T, Vitale G, La Mura V. Turco L, et al. Liver Int. 2023 Jun;43(6):1183-1194. doi: 10.1111/liv.15559. Epub 2023 Apr 17. Liver Int. 2023. PMID: 36897563 Review.

9

Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension.

Wei ZG, Wei FX, Shao ZW, Su GH, Qi XP, Zhang YC. Wei ZG, et al. Ther Clin Risk Manag. 2018 Dec 24;15:45-57. doi: 10.2147/TCRM.S184863. eCollection 2019. Ther Clin Risk Manag. 2018. PMID: 30636878 Free PMC article. Review.

10

Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.

Frishman WH, Henderson LS, Lukas MA. Frishman WH, et al. Vasc Health Risk Manag. 2008;4(6):1387-400. doi: 10.2147/vhrm.s3148. Vasc Health Risk Manag. 2008. PMID: 19337551 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 30521289

16 results

Results by year